Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.

Fulltext:
48075.pdf
Embargo:
until further notice
Size:
184.9Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2005Source
Surgery, 137, 2, (2005), pp. 246-9ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Surgery
Nuclear Medicine
Gynaecology
Pathology
Journal title
Surgery
Volume
vol. 137
Issue
iss. 2
Page start
p. 246
Page end
p. 9
Subject
DCN 2: Functional Neurogenomics; DCN 3: Neuroinformatics; N4i 1: Pathogenesis and modulation of inflammation; NCMLS 2: Immune Regulation; NCMLS 7: Chemical and physical biology; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; UMCN 1.1: Functional Imaging; UMCN 1.2: Molecular diagnosis, prognosis and monitoring; UMCN 1.3: Tumor microenvironment; UMCN 1.4: Immunotherapy, gene therapy and transplantationAbstract
Removal of a primary colorectal tumor resulted in an increase in metabolic activity in its liver metastasis. Concomitantly, levels of angiostatin and endostatin in urine and plasma, respectively, dropped. This finding indicates that the primary tumor suppressed angiogenesis in its distant metastasis, and that removal of the primary lesion caused a flare-up in vessel neoformation and, thus, enhanced metabolic activity in its liver metastasis.
This item appears in the following Collection(s)
- Academic publications [229133]
- Electronic publications [111631]
- Faculty of Medical Sciences [87757]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.